Tumor necrosis factor-α induced pathology in the rat brain: Characterization of stereotaxic injection model

Folia Neuropathologica

Volumn 36, Issue 1, 1998, Pages 52-62

  Gła̧biński, Andrzej ^a   Krajewski, Stanisław ^b   Rafałowska, Janina ^b,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Blood brain barrier; Brain edema; Brain pathology; Brain trauma; Meningitis; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ASTROCYTE; BRAIN; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; GRANULOCYTE; HISTIOCYTE; IMMUNOHISTOCHEMISTRY; INJECTION; MENINX; MYELIN SHEATH; NECROSIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; RAT; STEREOTAXIC SURGERY; WISTAR RAT;

ANIMALS; ASTROCYTES; BRAIN; FEMALE; GRANULOCYTES; HISTIOCYTES; IMMUNOHISTOCHEMISTRY; INJECTIONS; MENINGES; MYELIN SHEATH; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, WISTAR; STEREOTAXIC TECHNIQUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031627202     PISSN: 00283894     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Brosnan CF, Selmaj K, Raine CS: Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol, 1988, 18, 87-94.
2. De Groot J: The rat forebrain in stereotaxic coordinates. NV Noord-Hollandsche Uitgevers Maatschappij, Amsterdam, 1963.
3. Dinarello CA, Cannon JG, Wolff SM, Bernheini HA, Beutler B, Cerami A, Figari IS, Palladino MA, O'Connor JV: Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med, 1986, 163, 1433-1450.
4. Dinarello CA: Biology of interleukin 1. FASEB J, 1988, 2, 108-115.
5. Ellison MD, Merchant RE: Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats. J Neuroimmunol, 1991, 33, 245-251.
6. Giulian D, Lachman LB: Interleukin-1 stimulation of astroglial proliferation after brain injury. Science, 1986, 228, 497-499.
7. Giulian D, Chen J, Ingeman JE, George JK, Noponen M: The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci, 1989, 9, 4416-4429.
8. Gła̧biński AR, Tani M, Aras S, Stoler MH, Tuohy VK, Ransohoff RM: Regulation and function of central nervous system chemokines. Int J Develop Neurosci, 1995a, 13, 153-165.
9. Gła̧biński AR, Tani M, Touhy VK, Tuthill R, Ransohoff RM: Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalitis. Brain Behav Immun, 1995b, 9, 315-330.
10. Gła̧biński AR, Tani M, Strieter RM, Touhy VK, Ransohoff RM: Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol, 1997, 150, 617-630.
11. Grau GE, Fajardo LF, Piguet P-F, Allet B, Lambert P-H, Vassali O: Tumor necrosis factor (Cachectin) as an essential mediator in murine cerebral malaria. Science, 1987, 237, 1210-1212.
12. Grau GE, Kindler V, Piguet P-F, Lambert P-H, Vassali P: Prevention of experimental cerebral malaria by anticytokine antibodies. J Exp Med, 1988, 168, 1499-1504.
13. Hofman FM, Hinton DR, Johnson K, Merril JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med, 1989, 170, 607-612.
14. Ikejima T, Okusawa S, Ghezzi P, van der Meer JAVM, Dinarello CA: Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis, 162, 215-223.
15. Klysik J, Konarzewska-Zglińska A, GaŁa̧zka G, Uznanski B, Okruszek A, Guga P, Wilk A, Koziołkiewicz M, Tchorzewski H, Zembala M, Stec WJ: Synthesis and expresion in E. coli of the gene for tumor necrosis factor (h TNF apha). Arch Immunol Ther Exp, 1991, 39, 349-355.
16. Leist TP, Frei K, Kam-Hansen S, Zinkernagel RM, Fontana A: Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. J Exp Med, 1988, 167, 1743-1748.
17. Mustafa MM, Ramilo O, Olsen KD, Frankil PS, Hansen EJ, Beutler B, McCracken GH: Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J Clin Invest, 1989a, 84, 1253-1259.
18. Mustafa MM, Lebel MH, Ramilo O, Olsen KD, Reisch JS, Beutler B, McCracken GH: Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr, 1989b, 208-213.
19. Nadal D, Leppert D, Frei K, Gallo P, Lamche H, Fontana A: Tumour necrosis factor-alpha in infectionus meniogitis. Arch Dis Child, 1989, 64, 1274-1279.
20. Powell MB, Steineman L: The role of lymphotoxin and TNF in demyelinatiing diseases of the CNS. In: Tumor necrosis factors: The molecules and their emerging role in medicine. B Beutler (ed), Raven Press Ltd, New York, 1992, 355-369.
21. Quagliarello VJ, Wispelwey B, Long WJ, Scheid WM: Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. J Clin Invest, 1991, 87, 1360-1366.
22. Ramilo O, Saez-Llorens X, Mertsola J, Jafari H, Olsen KD, Hansen EJ, Yoshinaga M, Ohkawara S, Nariuchi H, McCracken GH: Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med, 1990, 172, 497-507.
23. Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, Tuomanen E: The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med, 1990, 171, 439-448.
24. Scheld WM, Quagliarello VJ, Wispelwey B: Potential of host cytokines in Haemophilus influenzae lipopolysaccharide-induced blood-brain permeability. Ped Infect Dis J, 1989, 910-912.
25. Selmaj K: The role of cytokines in inflammatory conditions of the central nervous system. Semin Neurosci, 1992, 4, 221-229.
26. Selmaj KW, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol, 1988, 23, 339-346.
27. Selmaj K, Raine CS, Cannella B, Brosnan CF: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest, 1991, 87, 949-954.
28. Sharief MK, Hentges R: Association between tumot necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med, 1991, 325, 467-472.
29. Simmons RD, Willenborg DO: Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J Neurol Sci, 1990, 100, 37-42.
30. Sternberger LA, Hardy PH Jr, Cuculis FF, Meyer HG: The unlabelled antibody enzyme method of immunocytochemistry: preparation and properties of solouble antigen-antibody complex (horseradish peroxidase-antiperoxidase) and its use in identification of spirochetes. J Histochem, 1970, 18, 315-333.
31. Takamiya Y, Kohsaka S, Toya S, Otani M, Mikoshiba K, Tsukada Y: Possible association of platelet-derived growth factor (PDGF) with the appearance of reactive astrocytes following brain injury in situ. Brain Res, 1986, 383, 305-309.
32. Waage A, Halstensen A, Shalaby R, Brandtz P, Kierulf P, Espevik T: Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. J Exp Med, 1989, 170, 1859-1867.